UBS raised the firm’s price target on Celestica (CLS) to $350 from $208 and keeps a Neutral rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLS:
- Celestica price target raised to $385 from $230 at Stifel
- Celestica price target raised to $305 from $238 at TD Securities
- Celestica price target raised to $370 from $300 at BMO Capital
- Celestica price target raised to $440 from $340 at Goldman Sachs
- Celestica price target raised to $388 from $305 at JPMorgan